These observations suggest that the higher sensitivity of EwS toward Elesclomol may be caused by the relatively higher expression of SOX6 in EwS compared to other cancers such as osteosarcoma and melanoma (Supplementary Fig. 4c). The gene discussed is SOX6; the disease is cancer.